TGEN(TGEN)
TGEN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $26M | $59M |
| Low | $25M | $55M |
| High | $27M | $63M |
| EBITDA Avg | $-6M | $5M |
| Low | $-7M | $5M |
| High | $-5M | $6M |
| EBIT Avg | $-7M | $5M |
| Low | $-8M | $4M |
| High | $-6M | $5M |
| Net Income Avg | $-7M | $4M |
| Low | $-8M | $3M |
| High | $-6M | $4M |
| EPS Avg | $-0.25 | $0.13 |
| Low | $-0.28 | $0.12 |
| High | $-0.22 | $0.14 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $6M | $7M | $10M | $13M | $17M | $20M |
| Low | $6M | $6M | $8M | $11M | $14M | $17M |
| High | $7M | $9M | $11M | $14M | $18M | $22M |
| EBITDA Avg | $-2M | $-1M | $-411,639 | $663,956 | $2M | $4M |
| Low | $-2M | $-1M | $-501,506 | $597,129 | $2M | $3M |
| High | $-1M | $-640,056 | $-288,456 | $712,709 | $2M | $4M |
| EBIT Avg | $-2M | $-1M | $-649,555 | $427,674 | $2M | $4M |
| Low | $-2M | $-2M | $-739,422 | $360,847 | $2M | $3M |
| High | $-1M | $-882,364 | $-526,372 | $476,427 | $2M | $4M |
| Net Income Avg | $-2M | $-1M | $-698,365 | $299,303 | $1M | $3M |
| Low | $-2M | $-2M | $-788,232 | $246,510 | $1M | $2M |
| High | $-1M | $-931,174 | $-575,182 | $337,818 | $2M | $3M |
| EPS Avg | $-0.06 | $-0.05 | $-0.02 | $0.01 | $0.05 | $0.09 |
| Low | $-0.07 | $-0.05 | $-0.03 | $0.01 | $0.04 | $0.08 |
| High | $-0.05 | $-0.03 | $-0.02 | $0.01 | $0.06 | $0.11 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |